bioRxivBioinformaticsPreprint
Differential gene expression in the interactome of the Human Dopamine transporter in the context of Parkinson's disease
Roberto Navarro QuiroziD, Ana Lígia ScottiD, Eric Allison PhilotiD, Linda Atencio IbarraiD, Cecilia M. Fernandez-PonceiD, Gustavo ArocaiD, Andrés Cadena BonfantiiD, Lorena Gómez EscorciaiD, Elkin Navarro QuiroziD
Abstract
BackgroundThe human dopamine transporter is the main regulator of dopamine tone and an intricate network exists to regulate the expression, conformation, and kinetics of the hDAT. hDAT dysfunction is directly related to Parkinsons disease. The objective of this work is to evaluate the differential gene expression in the interactome of the Dopamine transporter in the context of Parkinsons disease. MethodsTo do this, we evaluated hDAT interaction data in string-db, mint.bio, IntAct, reactome, hprd and BioGRID, subsequently, data was obtained from the differential gene expression of mRNA and miRNAs for this hDAT interactome in the context of PD. ResultsThe analysis of the differential expression changes of genes of the hDAT interactome in tissues of patients with PD compared with tissues of individuals without PD, allowed to identify an expression pattern of 32 components of the hDAT interactome, of which 31 presented a negative change proportion in PD. ConclusionsWe found a total of 90 miRNAs that could regulate the expression of 27 components of the hDAT interactome, at the same time, 39 components of the hDAT interactome may participate in 40 metabolic pathways. Together, these findings show a systematic effect on the hDAT-mediated dopamine internalization process in patients with Parkinsons, which would contribute to a greater susceptibility to neuronal oxidative stress in PD patients.
- organism: human
- assay: bulk RNA-seq
- research focus: differential expression
- approach: statistical model
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A dominant-negative variant in the dopamine transporter PDZ-binding motif is linked to parkinsonism and neuropsychiatric disease
Freja Herborg, Kathrine Louise Jensen, … Ulrik Gether·JCI InsightPeer-reviewed·Aug 10, 2021
- Genes critical for development and differentiation of dopaminergic neurons are downregulated in Parkinson's disease
Aditi Verma, Reddy Peera Kommaddi, … Vijayalakshmi Ravindranath·Journal of Neural TransmissionPeer-reviewed·Feb 23, 2023
- Integrative Transcriptomic Analysis Identifies Novel Mitochondrial Gene Targets in Parkinson's Disease.
Anusree Damodaran, Sanskriti Goswami, … Sonia Verma·Molecular NeurobiologyPeer-reviewed·Jan 1, 2026
- Transcriptome responses to reduced dopamine in the Substantia Nigra Pars Compacta reveals a potential protective role for dopamine.
M. Koltun, Karol Cichewicz, … Jay Hirsh·bioRxiv·Sep 9, 2019
- Correcting differential gene expression analysis for cyto-architectural alterations in substantia nigra of Parkinson's disease patients reveals known and potential novel disease-associated genes and pathways
Federico Ferraro, Christina Fevga, … Marcel J. T. Reinders·CellsPeer-reviewed·Jan 7, 2022
- Imbalanced mitochondrial dynamics in human and mouse PD brains
Harry J. Brown, Rebecca Zhangqiuzi Fan, … Kim Tieu·bioRxiv·Jan 27, 2025